| Date | Form | Description | Docs | XBRL | Pages |
| 01/18/05 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/18/05 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 12/22/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
51 | |
| 02/13/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
49 | |
| 01/29/03 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/29/02 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
48 | |
| 02/01/01 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/29/01 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/28/00 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 | |
| 03/31/99 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 |
Latest News & Events
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program
Read More...Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference
Read More...Anixa Biosciences to Present at Biotech Showcase 2020
Read More...Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.